id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-293678-jfjc7wjb	Haroun-Díaz, Elisa	SEVERE ASTHMA DURING THE COVID-19 PANDEMIC: CLINICAL OBSERVATIONS	2020-06-27		.txt	text/plain	334	33	59	title: SEVERE ASTHMA DURING THE COVID-19 PANDEMIC: CLINICAL OBSERVATIONS It is 110 estimated that the global economic burden of asthma is between 1.5 and 3 billion euros 111 annually, and higher costs are associated with greater disease severity (5). Severe asthma affects 3.9% of asthmatic patients (5). It is defined as an inflammatory 113 chronic respiratory disease that remains uncontrolled despite optimal therapy and 114 treatment of contributing factors, or which worsens when high-dose treatment is 115 decreased (6). Around 50% of patients with severe asthma experience uncontrolled or 116 partially controlled symptoms despite maximal treatment (5). The aim of this study is to determine the prevalence and characterization of COVID-19 120 infection among patients with severe asthma according to ERS/ATS criteria who 121 presented to our allergy department during the COVID-19 pandemic. ATS guidelines on definition, evaluation and treatment of 219 severe asthma	./cache/cord-293678-jfjc7wjb.txt	./txt/cord-293678-jfjc7wjb.txt